Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Histologically confirmed, primary, previously untreated, resectable squamous cell carcinoma of the oral cavity considered clinically and radiologically as intermediate or high risk, classified II ( with large (≥ 3 cm and ≤ 4cm) cT2cN0cM0 tumors or any cT2cN0cM0 tumor invading neighboring structures) III or IVa according to the American Joint Committee on Cancer~* Adequate liver and renal function~Exclusion criteria:~* Other malignancy~* Abnormal cardiac status~* Autoimmune disease~* Serious concurrent uncontrolled medical disorder~* Systemic treatment with corticosteroids or other immunosuppressive agents within 30 days prior to IPH2201 first administration.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- single arm (Type: EXPERIMENTAL): IPH2201 followed by standard surgery and standard postsurgical adjuvant therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).